Azure Health Technology Limited (NSX:VTL) Initiation Report
Azure Health Technology Limited (NSX:VTL) trading as VGI Health Technology is pleased to announce that Pitt Street Research has issued an Initiation Report.
Companies in the News
Biotech
Azure Health Technology Limited (NSX:VTL) Appointment of cGMP Manufacturer
Azure Health Technology Limited trading as VGI Health Technology (NSX:VTL) is pleased to announce that an additional current Good Manufacturing Practice (cGMP) manufacturer has been appointed in the US.
Anatara Lifesciences Ltd (ASX:ANR) Progressing Towards First Human Clinical Studies
Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals is pleased to provide this update on clinical trial activities.
IQX Limited (NSX:IQX) Progress of Clinical Programs
iQX Limited (iQX Ltd) (NSX:IQX) would like to announce that Life Science Biosensor Diagnostics Pty Ltd (LSBD) in which iQX Ltd holds a 19% equity position, has received approval from the Harvard Longwood campus Institutional Review Board (IRB) to commence a clinical validation study to test patient samples from a COVID-19 repository.
Anatara Lifesciences Ltd (ASX:ANR) Q3 FY21 Activities Report
Anatara Lifesciences (ASX:ANR), a developer of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans, is pleased to provide this activities report for the quarter ending 31 March 2021, along with the Company's Appendix 4C cash flow report.
Anatara Lifesciences Ltd (ASX:ANR) Ethics Approve Adult Psychological Functioning Trial start
Anatara Lifesciences (ASX:ANR) is pleased to advise that it is has received Human Research Ethics Committee (HREC) approval to undertake a clinical trial on the effects of 3FDC dietary supplementation on psychological functioning in an adult population.
Anatara Lifesciences Ltd (ASX:ANR) Announces Australian Patent Grant for Detach
Anatara Lifesciences Ltd (ASX:ANR) is pleased to announce the grant of patent number AU2019204496 entitled "Anti-diarrhea formulation which avoids antimicrobial resistance".
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
Social Media
